Read the open-letter authored by the European Federation of Neurological Disorders [EFNA]
Disease specific information
Epilepsy – COVID-19 & Epilepsy Information International Bureau for Epilepsy (IBE)
MS – Coronavirus disease (COVID-19) and MS European Multiple Sclerosis Platform (EMSP)
Stroke – Covid-19 Updates Stroke Alliance for Europe (SAFE)
Migraine – Migraine & COVID-19 FAQ Migraine Association of Ireland (MAI)
Brain tumour – COVID-19 Information The International Brain Tumour Alliance (IBTA)
Huntingtons Disease – COVID-19 & Huntington’s Disease European Huntington Association (EHA)
Parkinson’s Disease – Important information about COVID-19 European Parkinson’s Disease Association (EPDA)
Myasthenia Gravis – Guidance for the management of Myasthenia Gravis (MG) during the COVID-19 pandemic European Association of Myasthenia Gravis Patients’ Associations (EUMGA)
Ataxia – Implications of coronavirus (covid-19) for people with ataxia Ataxia UK
Friedreich’s Ataxia – Information About COVID-19 for Friedreich’s Ataxia Patients Ataxia UK
Dystonia – Dystonia without botulinum toxin (COVID-19) Dystonia Europe
Myalgic Encephalomyelitis – The Influence of Covid-19 on sensitive ME/CFS Patients (survey) European ME Alliance
ADHD – ADHD Europe: Guidelines ADHD Management & Support ADHD Europe
Tourette Syndrome – What if… A practical guide to possible problems Katie Skinner (Specialist Teacher SEMH) via Tourettes Action UK
If your organisation has resources / disease-specific information to share, please let us know.
